Table 3.
All patients, n | 6102 |
Age (years) | 63 [54-71] |
Sex (male) | 4290 (70.3) |
BMI | 28.8 [26.0-32.3] |
Comorbidities (No. with data) | |
Hypertension | 3075 (50.4) |
Diabetes mellitus | 1507 (24.7) |
Chronic cardiovascular disease | 793 (13.0) |
Chronic pulmonary disease | 622 (10.2) |
Chronic kidney disease | 439 (7.2) |
Disease chronology from symptoms onset | |
To hospital admission (days) | 7 [5-9] |
To ICU admission (days) | 9 [7-12] |
To IMV start (days) | 10 [7-13] |
Symptoms at hospital admission | |
Fever | 5123 (82.9) |
Dry cough | 3740 (61.3) |
Productive cough | 790 (12.9) |
Shortness of breath | 4432 (72.6) |
Anosmia | 442 (7.2) |
Headache | 834 (13.7) |
Myalgia | 1646 (27.0) |
Diarrhea | 1320 (21.6) |
Severity scores at ICU admission | |
SOFA | 5 [4-7] |
APACHE II | 12 [9-16] |
Vital signs at ICU admission | |
Temperature (°C) | 36.8 [36.0-37.5] |
Mean arterial pressure (mmHg) | 88 [75-100] |
Respiratory rate (bpm) | 25 [21-31] |
Blood gases and laboratory parameters at ICU admission | |
PaO2/FiO2 (mmHg) | 112.5 [80.6-163.3] |
PaCO2 (mmHg) | 39.0 [34.0-47.0] |
pH | 7.41 [7.34-7.46] |
Lymphocyte count (×109/L) | 0.69 [0.47-0.99] |
D-dimer (ng/mL) | 1000.0 [518.0-2334.75] |
C-reactive protein (mg/L) | 128.0 [61.5-220.0] |
Ferritin (pg/mL) | 1142.0 [605.7-1880.3] |
IL-6 (pg/mL) | 86.6 [31.6-222.3] |
Interventions | |
IMV | 4638 (76.0) |
Prone position | 3667 (60.1) |
Tracheostomy | 1812 (29.7) |
ECMO | 164 (2.7) |
Renal replacement therapy | 549 (9.7) |
Complications | |
ARDS | 4792 (78.6) |
Bacterial pneumonia | 1861 (30.5) |
Pulmonary embolism | 568 (9.3) |
Coagulation disorder | 1458 (23.9) |
Acute renal injury | 1953 (32.0) |
Liver disfunction | 1825 (29.9) |
Outcomes | |
ICU length (days) | 13 [7-27] |
IMV length (days) | 15 [8-27] |
Hospital length (days) | 23 [14-40] |
In-hospital mortality | 1911 (31.4) |
APACHE-II: Acute Physiology and Chronic Health Evaluation; ARDS: acute respiratory distress syndrome; BMI: body mass index; ECMO: extracorporeal membrane oxygenation; ICU: intensive care unit; IL-6: interleukin-6; IMV: invasive mechanical ventilation; SOFA: Sequential Organ Failure Assessment.
Data are expressed as n (%) or median [interquartile range].